Catalyst Wire Dossier Catalyst Wire Dossier

HAI-FOLFOX regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HAI-FOLFOX regimen, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer [Phase 2, Phase 3]

See pricing